Hurricane-related IV fluid shortage could hurt medical device makers (Oct 17)
Corrects paragraph 3 in Oct. 17 story to say Baxter expects to meet 90% to 100% of allocation for certain products, not all products. The story was previously refiled to correct dateline
By Manas Mishra and Christy Santhosh
Oct 17 (Reuters) -A shortage of intravenous (IV) saline fluids due to Hurricane Helene is forcing hospitals to defer non-urgent surgeries, and could hurt companies that make medical devices for elective procedures if the supply crunch persists, analysts said.
Baxter International's BAX.N North Carolina plant, which makes 60% of the nation's supply of IV fluids and some key dialysis solutions, was closed for production late last month due to hurricane-related flooding.
Since then, hospitals have postponed elective surgeries even as the U.S. government, Baxter and other suppliers have rushed to bring in supplies from other facilities, including from overseas. Baxter has said it aimed to return to 90% to 100% allocation of certain IV solutions by the end of 2024.
The big question for medical device makers is how soon the shortage can be resolved, said Barclays analyst Matt Miksic in an interview.
If resolved soon, "whatever gets pushed out of this quarter will likely get picked up the following quarter in terms of delayed surgeries," said Miksic. "We wouldn't expect at this point (a) significant.. sustaining impact on the stocks."
J&J became the first medical device company to flag a potential hit on Tuesday, when it warned that the IV saline shortages could impact surgical procedures across its portfolio if they persist.
During a surgery, patients are administered a normal saline solution or a type of IV fluid called Lactated Ringer's to replenish lost fluids.
Germany's Fresenius and medtech company B. Braun Medical said last week they were ramping up production of IV fluids to mitigate the shortage.
Device makers including Boston Scientific BSX.N, Edwards Lifesciences EW.N, Medtronic MDT.N and Stryker SYK.N, and hospital operators such as HCA Healthcare HCA.N and Tenet Healthcare THC.N are likely to face questions about the potential impact from the shortage when they report earnings in the coming weeks.
Baxter is expected to report its quarterly earnings on Nov. 8.
Given that the shortage is not expected to last too long, the impact on hospital operators and other providers should be modest in the fourth quarter, Jefferies analyst Brian Tanquilut said in a Wednesday research note.
Morningstar analyst Julie Utterback said the recent storms could be a "short-term concern" for HCA, and do not typically change the long-term outlook for such hospital operators.
Reporting by Manas Mishra and Christy Santhosh in Bengaluru; Editing by Shinjini Ganguli
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
